- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02413619
Refractive Consequences of Epiretinal Membrane Surgery (EPIREF)
Epiretinal membrane is treated with vitrectomy and peeling. Afterwards cataract is usually developed, which requires a cataract surgery.
The aim of this study is to investigate the refractive consequences of surgery for Epiretinal membrane and cataract.
Investigators investigate the sequence of surgery in patients having surgery for Epiretinal membrane and cataract in a prospective clinically randomized intervention trial. Patients are randomized to 1) start with vitrectomy, 2) start with cataract surgery, 3) combined surgery. Investigators want to find the sequence of surgery that gives the most optimal refractive result, the most stabile intraocular lens, and the minimal loss of corneal endothelial cells.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Aim: To evaluate the impact of the sequence of surgery on the Refractive Error and the Corneal Endothelial Count in phakic individuals undergoing surgery for Epiretinal membrane.
Study design: Prospective interventional randomized clinical trial. Primary outcome: Refractive error (i.e. Intraocular lens power prediction error), Corneal Endothelial Count, and postoperative macular oedema.
Secondary outcome: Changes in axial length, anterior chamber depth and keratometry; the accuracy of formulas used to calculate the power of the intraocular lens.
Study population:
Identification of participants: Individuals referred to the Macular Surgery Clinic, Surgical Retina Team, Department of Ophthalmology, Glostrup University Hospital, Copenhagen, Denmark. The individuals should be signed up for surgery because of Epiretinal membrane at the clinic.
Method:
Individuals are randomized to the possible sequences of surgery (i.e. start with cataract surgery, start with vitrectomy, or combined surgery). Based on an estimated clinical relevant refractive prediction error of 0,50 diopter and a standard deviation of 0,50 diopter, a number of 20 individuals in each of the three groups are needed to obtain a power of 80 % and a type 1 error of 5 %. Total number of individuals is thus 60.
Clinical examinations are performed preoperatively and 2 weeks after each surgery (cataract surgery, vitrectomy or combined surgery), and 3 and 12 months postoperatively. The examinations include best corrected distance visual acuity, autorefraction/keratometry (Retinomax®, Nikon, Tokyo, Japan), subjective refraction, slit-lamp examination, fundoscopy and tonometry. Biometry by IOLMaster (Carl Zeiss, Meditec AG, Germany), intraocular power calculation with the SRK/T formula. Pentacam Scheimpflug Cornea tomography (Topcon, Tokyo, Japan). Corneal Endothelial Count obtained by three images of the central region of the corneal endothelium (Topcon SP-3000P, Tokyo, Japan). Heidelberg Optical Coherence Tomography, (Heidelberg Engineering, Heidelberg, Germany).
Sequence of surgery depends on randomization. In all cases a standard phacoemulsification (scleral tunnel or clear corneal incision) with in-the-bag intraocular lens implantation. In combined surgery, the cataract surgery is performed before vitrectomy during the same session. Vitreoretinal procedures include a standard three-port 23 gauge pars plana vitrectomy, membrane peeling, and the use of dyes. Cataract surgery is performed by one of two experienced surgeons, and vitrectomy is carried out by one experienced surgeon.
Analysis: A computer database will be created as a fill-in form to record all patient data, and a masked statistical analysis of all outcome measures will be performed. Statistical analysis will be performed to determine differences in baseline data among the three groups (age, sex, visual acuity, keratometry, axial length, anterior chamber depth, Corneal Endothelial Count). To identify independent predictors for all outcome measures at different follow-up times, multivariate regression analysis is performed. All calculations will be performed using SAS software.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
DK
-
Glostrup, DK, Denmark, 2600
- Eye Department Glostrup Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion criteria:
- A diagnosis of Epiretinal membrane,
- visual complaints consistent with Epiretinal membrane,
- age more than 50 years,
- refraction less than ± 5 diopters and astigmatism less than 3 diopters,
- indication for vitrectomy is only Epiretinal membrane.
Exclusion criteria:
- Previous intraocular surgery or laser-refractive procedure.
- Use of intraocular gas tamponade during the vitrectomy.
- Intraoperative manipulation of the intraocular lens.
- Serious complications (endophthalmitis, vitreous haemorrhage or retinal detachment).
- History of previous head or ocular trauma.
- Sulcus fixation of intraocular lens
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Start cataract
Patients start having cataract surgery.
After one month they undergo vitrectomy
|
Cataract surgery
|
Active Comparator: start vitrectomy
Patients start having vitrectomy.
After one month they undergo cataract surgery.
|
Vitrectomy
|
Active Comparator: combined surgery
Combined cataract surgery and vitrectomy at the same time
|
Combined vitrectomy and cataract surgery at the same time
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Refractive Error
Time Frame: One year
|
Prediction error of intraocular lens calculation (measured in diopters)
|
One year
|
Corneal endothelial count
Time Frame: One year
|
measured in number of cells per square millimeter (mm2)
|
One year
|
Macula anatomy
Time Frame: One year
|
Macula-anatomy success of surgery, i.e. the postoperative decrease of macula thickness or postoperative macular oedema.
Measured in millimeter.
|
One year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Anterior Chamber Depth
Time Frame: One year
|
measured in millimeter (mm)
|
One year
|
Axial length
Time Frame: One year
|
measured in millimeter (mm)
|
One year
|
Collaborators and Investigators
Investigators
- Principal Investigator: Hassan Hamoudi, MD, Eye Department Glostrup Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EPIREF
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Epiretinal Membrane
-
Medical University of GrazCompletedEpiretinal Membrane of Both EyesAustria
-
Centre Hospitalier Universitaire DijonTerminatedEpiretinal Membrane SurgeryFrance
-
University of RegensburgCompletedIdiopathic Epiretinal Membrane, CataractGermany
-
Centre Hospitalier Universitaire DijonCompletedEpiretinal Membranes
-
Centre Hospitalier Universitaire DijonRecruitingSurgery for Cataract | Surgery for and Idiopathic Epiretinal MembraneFrance
-
Vienna Institute for Research in Ocular SurgeryCompleted
-
The Ludwig Boltzmann Institute of Retinology and...Completed
-
Nantes University HospitalCompleted
-
IRCCS Policlinico S. MatteoCompleted
-
Changhua Christian HospitalCompletedEpiretinal Membrane | Internal Limiting Membrane WrinklingTaiwan
Clinical Trials on Cataract surgery
-
Iladevi Cataract and IOL Research CenterCompletedCataract Surgery | Shallow Anterior Chamber | PhacoemulsificationIndia
-
Technolas Perfect Vision GmbHCompletedCataractCzech Republic, India
-
University of OklahomaCompletedPrimary Open Angle Glaucoma | Cataract | Pigmentary GlaucomaUnited States
-
Technolas Perfect Vision GmbHCompletedCataractCzech Republic, India
-
Glaukos CorporationCompletedOpen-Angle GlaucomaUnited States
-
Ziemer Ophthalmic Systems AGRecruiting
-
Technolas Perfect Vision GmbHCompleted
-
Sun Yat-sen UniversityCompleted
-
Guy's and St Thomas' NHS Foundation TrustCompletedCataract | Surgery
-
University Hospital, BordeauxCompleted